文献速递心力衰竭与心肌病血脂与心血管预防

既往心力衰竭对COVID-19住院患者预后的影响

Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.
PubMed 文献 · J Am Coll Cardiol · 2020-10-28

本研究回顾性分析了纽约市5家医院2020年2月27日至6月26日收治的6439例COVID-19住院患者,比较有或无既往心力衰竭(HF)病史者的临床特征与结局。结果显示,既往HF患者住院时间更长、机械通气风险和院内死亡风险均显著更高,且这些不良结局与左心室射血分数(LVEF)或肾素-血管紧张素-醛固酮抑制剂使用无关。

要点

  • 既往HF使COVID-19住院患者机械通气风险增加至3.64倍(调整OR)。
  • 既往HF使COVID-19住院患者院内死亡风险增加至1.88倍(调整OR)。
  • HF患者的不良结局与LVEF及RAAS抑制剂使用无关。

核心结论

  • 既往心力衰竭病史与COVID-19住院患者更高的机械通气风险和院内死亡风险相关,且与左心室射血分数无关。

研究设计与样本

  • 回顾性分析纽约市5家Mount Sinai医院2020年2月27日至6月26日收治的6439例COVID-19住院患者。
  • 通过ICD-9/10编码识别既往HF病史,并手工查阅病历获取病因、功能分级和LVEF。

主要发现

  • 既往HF患者住院时间中位数为8天,无HF患者为6天(p < 0.001)。
  • 既往HF患者机械通气比例为22.8%,无HF患者为11.9%(调整OR 3.64,95%CI 2.56-5.16,p < 0.001)。
  • 既往HF患者院内死亡比例为40.0%,无HF患者为24.9%(调整OR 1.88,95%CI 1.27-2.78,p = 0.002)。
  • HF患者的不良结局与LVEF或肾素-血管紧张素-醛固酮抑制剂使用无关。

临床怎么用

  • 对COVID-19住院患者应评估既往心力衰竭病史以识别高危人群。
  • 既往HF患者需加强监护,警惕机械通气和死亡风险升高。

局限性

  • 本研究为单中心回顾性分析,结果可能受混杂因素影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with pre-existing heart failure (HF) are likely at higher risk for adverse outcomes in coronavirus disease-2019 (COVID-19), but data on this population are sparse. OBJECTIVES: This study described the clinical profile and associated outcomes among patients with HF hospitalized with COVID-19. METHODS: This study conducted a retrospective analysis of 6,439 patients admitted for COVID-19 at 1 of 5 Mount Sinai Health System hospitals in New York City between February 27 and June 26, 2020. Clinical characteristics and outcomes (length of stay, need for intensive care unit, mechanical ventilation, and in-hospital mortality) were captured from electronic health records. For patients identified as having a history of HF by International Classification of Diseases-9th and/or 10th Revisions codes, manual chart abstraction informed etiology, functional class, and left ventricular ejection fraction (LVEF). RESULTS: Mean age was 63.5 years, and 45% were women. Compared with patients without HF, those with previous HF experienced longer length of stay (8 days vs. 6 days; p < 0.001), increased risk of mechanical ventilation (22.8% vs. 11.9%; adjusted odds ratio: 3.64; 95% confidence interval: 2.56 to 5.16; p < 0.001), and mortality (40.0% vs. 24.9%; adjusted odds ratio: 1.88; 95% confidence interval: 1.27 to 2.78; p = 0.002). Outcomes among patients with HF were similar, regardless of LVEF or renin-angiotensin-aldosterone inhibitor use. CONCLUSIONS: History of HF was associated with higher risk of mechanical ventilation and mortality among patients hospitalized for COVID-19, regardless of LVEF.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Alvarez-Garcia J, Lee S, Gupta A, et al. Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19. J Am Coll Cardiol. 2020. PMID: 33129663. doi:10.1016/j.jacc.2020.09.549

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。